Skip to main content
Lasque Tiarc

‘Is this some kind of ‘don’t ask, don’t tell’ policy?’: what we heard this week

Vaseline 2 months ago

“What is this, like, a ‘don’t ask, don’t tell’ policy?” — Ivan Oransky, MD, medical news publishing expert, on the New England Journal of Medicine cutting off certain publications from advanced access to embargoed journal articles.

“You might as well throw a dart at a dartboard.” — James Simon, MD, of George Washington University in Washington, DC, discussing the pitfalls of testing testosterone levels in women.

“Surgery should not be ruled out just because they are in their 90s.” — Preeti Subhedar, MD, a breast surgeon in New York, comments on primary breast cancer surgery for non-peers.

“Why do we work under two separate rules, depending only on where we studied medicine?” — Tom Takubo, DO, a West Virginia state senator (R), about his state having two separate agencies to license osteopathic and allopathic physicians.

“Our schedule would be full of children with diarrhea and fever.” — Genon Wicina, MD, of Cleveland Clinic Martin Health in Florida, discusses rotavirus before there was a vaccine.

“We don’t need more reasons to know to take these drugs.” — Dan Azagury, MD, of Stanford Health in Palo Alto, California, on improvements from tirzepatide (Zepbound) and sleep apnea.

“You didn’t leave the data on the sidewalk for someone to float by and pick it up like it was an abandoned wallet.” — Rep. Michael Burgess, MD (R-Texas), commenting on the Change Healthcare cyberattack.

“The problem is partly due to the sheer lack of providers.” — Nora Siegler, a medical student at the University of Miami Miller School of Medicine, on pediatric eye care.

“All she has to do is pass the retake and she will be fine.” — Bryan Carmody, MD, who runs a medical education blog, comments on a Nepalese medical graduate who has joined a class action lawsuit against the National Board of Medical Examiners.